OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

Jazz Pharmaceuticals PLC/  IE00B4Q5ZN47  /

NASDAQ
08/11/2024  22:00:00 Chg. +4.5300 Volume Bid22:32:19 Ask22:32:19 Market Capitalization Dividend Y. P/E Ratio
123.6100USD +3.80% 868,080
Turnover: 65.01 mill.		 120.0000Bid Size: 200 125.4500Ask Size: 100 7.47 bill.USD - 18.87
GlobeNewswire 22/08 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 22/08 Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with th...
GlobeNewswire 08/08 Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 01/08 Zymeworks Announces Share Repurchase Program of up to $60 Million of its Common Stock
GlobeNewswire 01/08 Zymeworks Provides Corporate Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire 30/07 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 25/07 Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
GlobeNewswire 22/07 Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Gen...
GlobeNewswire 22/07 Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW191, a Novel Folate ...
Newsfile Corp 17/07 Analysts Hunt for Undervalued Biotech Stocks
GlobeNewswire 11/07 Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024
GlobeNewswire 17/06 Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-c...
GlobeNewswire 11/06 CanaQuest Announces Key Appointments to Team to Drive CQ-001 through Clinical Trials
GlobeNewswire 10/06 Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Secon...
GlobeNewswire 28/05 NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer
GlobeNewswire 28/05 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 03/05 Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 02/05 Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 30/04 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 15/04 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 11/04 Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
GlobeNewswire 28/03 Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors
GlobeNewswire 28/03 Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development
GlobeNewswire 27/03 Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire 07/03 Werewolf Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Busin...